Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Investigative Ophthalmology & Visual Science
|
June 28, 2005
Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury
Gabriel Sosne, Patricia L Christopherson, Ronald P Barrett, et al.
Annals of the New York Academy of Sciences
|
October 12, 2012
Thymosin β4: a potential novel dry eye therapy
Gabriel Sosne, Ping Qiu, George W Ousler, et al.
Cells
|
December 24, 2021
Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during <i>Pseudomonas aeruginosa</i>-Induced Corneal Infection
Yuxin Wang, Thomas W Carion, Abdul Shukkur Ebrahim, et al.
International Journal of Molecular Sciences
|
October 23, 2021
Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in <i>Pseudomonas aeruginosa</i>-Induced Keratitis
Yuxin Wang, Thomas W Carion, Abdul Shukkur Ebrahim, et al.
Experimental Eye Research
|
April 25, 2006
Thymosin beta4 inhibits benzalkonium chloride-mediated apoptosis in corneal and conjunctival epithelial cells in vitro
Gabriel Sosne, Abdul-Rahman Albeiruti, Brian Hollis, et al.
International Journal of Molecular Sciences
|
January 8, 2023
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial
Gabriel Sosne, Hynda K Kleinman, Clark Springs, et al.
Frontiers in Immunology
|
October 9, 2024
Activation of pro-resolving pathways mediate the therapeutic effects of thymosin beta-4 during <i>Pseudomonas aeruginosa</i>-induced keratitis
Yuxin Wang, Loveleen Banga, Abdul Shukkur Ebrahim, et al.
Experimental Eye Research
|
April 13, 2002
Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury
Gabriel Sosne, Elizabeth A Szliter, Ronald Barrett, et al.
Scientific Reports
|
July 14, 2018
RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model
Chae Eun Kim, Hynda K Kleinman, Gabriel Sosne, et al.
International Journal of Molecular Sciences
|
September 23, 2020
Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in <i>Pseudomonas aeruginosa</i> Induced Keratitis
Thomas W Carion, Abdul Shukkur Ebrahim, Spandana Alluri, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Investigative Ophthalmology & Visual Science
|
June 28, 2005
Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury
Gabriel Sosne, Patricia L Christopherson, Ronald P Barrett, et al.
Annals of the New York Academy of Sciences
|
October 12, 2012
Thymosin β4: a potential novel dry eye therapy
Gabriel Sosne, Ping Qiu, George W Ousler, et al.
Cells
|
December 24, 2021
Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during <i>Pseudomonas aeruginosa</i>-Induced Corneal Infection
Yuxin Wang, Thomas W Carion, Abdul Shukkur Ebrahim, et al.
International Journal of Molecular Sciences
|
October 23, 2021
Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in <i>Pseudomonas aeruginosa</i>-Induced Keratitis
Yuxin Wang, Thomas W Carion, Abdul Shukkur Ebrahim, et al.
Experimental Eye Research
|
April 25, 2006
Thymosin beta4 inhibits benzalkonium chloride-mediated apoptosis in corneal and conjunctival epithelial cells in vitro
Gabriel Sosne, Abdul-Rahman Albeiruti, Brian Hollis, et al.
International Journal of Molecular Sciences
|
January 8, 2023
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial
Gabriel Sosne, Hynda K Kleinman, Clark Springs, et al.
Frontiers in Immunology
|
October 9, 2024
Activation of pro-resolving pathways mediate the therapeutic effects of thymosin beta-4 during <i>Pseudomonas aeruginosa</i>-induced keratitis
Yuxin Wang, Loveleen Banga, Abdul Shukkur Ebrahim, et al.
Experimental Eye Research
|
April 13, 2002
Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury
Gabriel Sosne, Elizabeth A Szliter, Ronald Barrett, et al.
Scientific Reports
|
July 14, 2018
RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model
Chae Eun Kim, Hynda K Kleinman, Gabriel Sosne, et al.
International Journal of Molecular Sciences
|
September 23, 2020
Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in <i>Pseudomonas aeruginosa</i> Induced Keratitis
Thomas W Carion, Abdul Shukkur Ebrahim, Spandana Alluri, et al.
Page
of 4